Mar 12, 2026 08:32AM

Mar 12, 2026 08:30AM

Jul 18, 2024 09:15AM

Mar 27, 2023 04:05PM

Mar 7, 2023 07:30AM

Dec 8, 2022 07:30AM

Jul 18, 2022 07:05AM Entera Bio Announces Execution of Key Regulatory Milestones for EB613, the First Oral Anabolic Drug Proposed for the Treatment of Osteoporosis; Miranda Toledano Assumes CEO Position

May 16, 2022 08:00AM

325,125 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All